Advertisement
Screener

ORAGENICS, INC. (OGEN) Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

ORAGENICS, INC. Current Liabilities

ORAGENICS, INC. (OGEN) had Current Liabilities of $1.80 million as of 2023-12-31, per its 10-K filed 2024-03-29.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:LiabilitiesCurrent · last filed 2024-03-29

  • 2023-12-31: Liabilities, Current $1.80M.
  • 2023-09-30: Liabilities, Current $1.40M.
  • 2023-06-30: Liabilities, Current $1.14M.
  • 2023-03-31: Liabilities, Current $1.78M.
Period endLiabilities, CurrentLiabilities, Current as first filed
2023-12-31$1.80M
10-K · filed 2024-03-29
2023-09-30$1.40M
10-Q · filed 2023-11-09
2023-06-30$1.14M
10-Q · filed 2023-08-11
2023-03-31$1.78M
10-Q · filed 2023-05-12
2022-12-31$1.60M
10-K · filed 2024-03-29
2022-09-30$1.57M
10-Q/A · filed 2023-04-14
$1.50M
10-Q · filed 2022-11-14
2022-06-30$1.46M
10-Q/A · filed 2023-04-14
2022-03-31$1.41M
10-Q/A · filed 2023-04-14
2021-12-31$1.45M
10-K · filed 2023-04-17
2021-09-30$2.20M
10-Q · filed 2021-11-15
2021-06-30$2.12M
10-Q · filed 2021-08-16
2021-03-31$868.88K
10-Q · filed 2021-05-03
2020-12-31$1.34M
10-K/A · filed 2022-07-29
2020-09-30$1.10M
10-Q · filed 2020-11-10
2020-06-30$1.36M
10-Q · filed 2020-08-14
2020-03-31$2.03M
10-Q · filed 2020-05-15
2019-12-31$1.85M
10-K · filed 2021-03-01
2019-09-30$2.25M
10-Q · filed 2019-11-14
2019-06-30$1.89M
10-Q · filed 2019-08-14
2019-03-31$2.19M
10-Q · filed 2019-05-13
2018-12-31$1.17M
10-K · filed 2020-03-04
2018-09-30$1.56M
10-Q · filed 2018-11-13
2018-06-30$1.56M
10-Q · filed 2018-08-13
2018-03-31$1.18M
10-Q · filed 2018-05-15
2017-12-31$898.52K
10-K · filed 2019-03-29
2017-09-30$1.72M
10-Q · filed 2017-10-31
2017-06-30$1.08M
10-Q · filed 2017-08-14
2017-03-31$1.17M
10-Q · filed 2017-05-15
2016-12-31$1.34M
10-K · filed 2018-02-16
2016-09-30$909.28K
10-Q · filed 2016-11-14
2016-06-30$897.80K
10-Q · filed 2016-08-15
2016-03-31$1.08M
10-Q · filed 2016-05-16
2015-12-31$1.05M
10-K · filed 2017-02-27
2015-09-30$5.89M
10-Q · filed 2015-11-06
2015-06-30$5.60M
10-Q · filed 2015-08-07
2015-03-31$605.98K
10-Q · filed 2015-05-08
2014-12-31$796.27K
10-K · filed 2016-03-30
2014-09-30$739.51K
10-Q · filed 2014-11-03
2014-06-30$777.87K
10-Q · filed 2014-08-07
2014-03-31$938.10K
10-Q · filed 2014-05-09
2013-12-31$992.85K
10-K · filed 2015-02-27
2013-09-30$4.45M
10-Q · filed 2013-10-25
2013-06-30$1.39M
10-Q · filed 2013-08-12
2013-03-31$1.17M
10-Q · filed 2013-05-15
2012-12-31$1.26M
10-K · filed 2014-02-28
2012-09-30$1.75M
10-Q · filed 2012-11-14
2012-06-30$1.38M
10-Q · filed 2012-08-10
2012-03-31$1.48M
10-Q · filed 2012-05-15
2011-12-31$9.45M
10-K · filed 2013-03-26
2011-09-30$7.81M
10-Q · filed 2011-11-14
2011-06-30$1.79M
10-Q · filed 2011-08-05
2010-12-31$1.63M
10-K · filed 2012-04-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02